The study examined the role of the GDF-15 protein in liver disease in 626 participants over 6 years. GDF-15 is a stress-induced cytokine that is thought to protect against fibrosis progression and regulate energy and lipid homeostasis. The results showed that GDF-15 was positively associated with liver steatosis (by an increase of 37.14 units). However, in patients with higher alcohol intake, the interaction of GDF-15 with alcohol was negatively associated with liver stiffness, suggesting a protective role. Insulin resistance (HOMA-IR) was associated with increased steatosis, but its interaction with GDF-15 was inversely associated, suggesting a protective modulation. The study suggests that GDF-15 modulates liver steatosis and fibrosis in subjects with metabolic risk factors or lifestyle risk factors. The authors conclude that GDF-15 has potential as a therapeutic target and warrants further investigation of its role in the neuro-metabolic-immunological axis.